Basic Information
Cardiora is a biopharmaceutical company focused on developing new treatments for patients with end-stage heart failure, which is associated with high mortality, frequent hospitalizations, and poor quality of life.
Cardiora
Melbourne,Victoria,Australia
15~50 people
January 01, 2015
--
bob.soh@cardiora.com